service area for an entire project by increasing useable area and facilities to ensure all areas of the project are satisfactory to the tourists and perfectly completed with international standards and can
manufacturing processes, where such factors are material to the issuer's business or profitability. 17 7. The basis for any statements made by the issuer regarding its competitive position shall be disclosed. 8
1 (TRANSLATION) SAFARI WORLD PUBLIC COMPANY LIMITED PCL 0107537000351 Ref. No. 080/2019 4 December 2019 Subject: Notification of the Resolution of the Board of Director’s Meeting regarding of the schedule of EGM1/2020, Capital Decrease, Capital increase, an Increasing of investment cost in Carnival Magic Project, and compensation for design and construction to related person. To: Managing Director The Stock Exchange of Thailand Reference: 1. Information Memorandum on the Issuance and Offering of...
1 (TRANSLATION) SAFARI WORLD PUBLIC COMPANY LIMITED PCL 0107537000351 Ref. No. 080/2019 4 December 2019 Subject: Notification of the Resolution of the Board of Director’s Meeting regarding of the schedule of EGM1/2020, Capital Decrease, Capital increase, an Increasing of investment cost in Carnival Magic Project, and compensation for design and construction to related person. To: Managing Director The Stock Exchange of Thailand Reference: 1. Information Memorandum on the Issuance and Offering of...
, operates the business of manufacturing and distribution of dialysis and medical equipment, later in February 2018, NCLpurchased some shares from a shareholder, making it the major shareholder with 52.80% of
overview of performance. Unit : Million Baht For the three-months ended 31 March Items Increased (Decreased) 2019 2018 Amount Percentage 1 Revenue from steel tower manufacturing 226.94 177.01 49.93 28.21 2
. Unit : Million Baht For the three-months ended 31 March Items Increased (Decreased) 2018 2017 Amount Percentage 1 Revenue from steel tower manufacturing 177.01 249.73 (72.72) (29.12) 2 Revenue from sale
solution and other medical product manufacturing and trading business. Previously the company held 44% of all shares. Later in February 2018, the company acquired additional shares from one of the
% % 2020 % 2019 % % Revenue from sale 272.47 41.07% 389.02 71.31% -29.96% 600.81 60.91% 795.91 66.61% -24.51% Revenue from manufacturing and service 105.03 15.83% 147.41 27.02% -28.75% 216.52 21.95% 376.15
in quarter 3/2020. Revenue from manufacturing and service of 419.16 million baht as 227.84 million baht decreased or 35.21 percent when compared to the same period of previous year of 647 million